Stay updated on Y90-Radioembolization Plus Nivolumab in Asian HCC Clinical Trial
Sign up to get notified when there's something new on the Y90-Radioembolization Plus Nivolumab in Asian HCC Clinical Trial page.

Latest updates to the Y90-Radioembolization Plus Nivolumab in Asian HCC Clinical Trial page
- Check3 days agoChange DetectedPage revision updated from v3.6.4 to v3.6.5, indicating a site version update. No user-visible changes to study details or navigation are evident.SummaryDifference0.1%

- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedThe page revision tag changed from v3.6.3 to v3.6.4, indicating a minor update to the ClinicalTrials.gov page.SummaryDifference0.1%

- Check24 days agoNo Change Detected
- Check38 days agoChange DetectedThe page's revision label was updated from v3.6.2 to v3.6.3, indicating a minor maintenance/update to the site rather than a change to the study information.SummaryDifference0.1%

- Check45 days agoChange DetectedThe page revision tag was updated to v3.6.2, replacing the previous v3.6.0, indicating a minor page update. This change does not alter study details, eligibility criteria, or results.SummaryDifference0.1%

- Check60 days agoChange DetectedThe page now shows a recruitment status update indicating the study is no longer enrolling. New navigation/help sections (How to Read a Study Record, Common Questions, How to Join a Study) were added, and a formatting change to the Intervention/Treatment heading plus a revision tag update (v3.6.0) were applied.SummaryDifference0.5%

- Check67 days agoChange DetectedThe page revision was updated from v3.5.4 to v3.5.5, reflecting a small internal update to the page record without changes to the study content.SummaryDifference0.1%

Stay in the know with updates to Y90-Radioembolization Plus Nivolumab in Asian HCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Y90-Radioembolization Plus Nivolumab in Asian HCC Clinical Trial page.